Kurve Therapeutics, Inc.
PrivateLast Round
Crowdfunding
Aug 9, 2022
Est. Valuation
$341.79M
Total Funding Raised
$50M
Company Overview
Kurve Therapeutics, Inc. is a medical technology and drug formulation company that develops treatments for neurodegenerative diseases. The company's core technology is its patented Controlled Particle Dispersion® (CPD), an intranasal drug delivery system designed to bypass the blood-brain barrier. This allows for more effective delivery of therapies for complex CNS disorders, including Alzheimer's disease, Parkinson's disease, and cognitive aging. The company's lead product is ViaNase®, a device that utilizes the CPD technology. Kurve Therapeutics acquired the assets of its predecessor, Kurve Technology, Inc. (founded in 2001), in March 2022 and is advancing the technology towards Phase III clinical trials. The company is focused on developing drug/device combination therapies that offer faster, more effective drug delivery to the central nervous system with the goal of reducing side effects and costs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kurve Therapeutics, Inc. Comparables
Compare Kurve Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rocket Science Health Corp. | 83% | |
| Zeteo Biomedical | 79% | |
| MetP Pharma AG | 78% | |
Kurve Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Aug 9, 2022 |
Kurve Therapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kurve Therapeutics, Inc.'s valuation, stock price, and market status.